Free Trial

Veeva Systems (VEEV) Stock Forecast & Price Target

Veeva Systems logo
$282.86 -2.50 (-0.88%)
Closing price 06/9/2025 03:59 PM Eastern
Extended Trading
$283.14 +0.27 (+0.10%)
As of 06/9/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Veeva Systems - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
2
Hold
8
Buy
15

Based on 25 Wall Street analysts who have issued ratings for Veeva Systems in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 25 analysts, 2 have given a sell rating, 8 have given a hold rating, and 15 have given a buy rating for VEEV.

Consensus Price Target

$269.80
-4.62% Downside
According to the 25 analysts' twelve-month price targets for Veeva Systems, the average price target is $269.80. The highest price target for VEEV is $329.00, while the lowest price target for VEEV is $192.00. The average price target represents a forecasted downside of -4.62% from the current price of $282.86.
Get the Latest News and Ratings for VEEV and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Veeva Systems and its competitors.

Sign Up

VEEV Analyst Ratings Over Time

TypeCurrent Forecast
6/10/24 to 6/10/25
1 Month Ago
5/11/24 to 5/11/25
3 Months Ago
3/12/24 to 3/12/25
1 Year Ago
6/11/23 to 6/10/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
15 Buy rating(s)
15 Buy rating(s)
15 Buy rating(s)
13 Buy rating(s)
Hold
8 Hold rating(s)
8 Hold rating(s)
8 Hold rating(s)
6 Hold rating(s)
Sell
2 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$269.80$254.92$255.28$228.25
Forecasted Upside-4.62% Downside7.74% Upside9.40% Upside23.39% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

VEEV Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

VEEV Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Veeva Systems Stock vs. The Competition

TypeVeeva SystemsMedical CompaniesS&P 500
Consensus Rating Score
2.52
2.81
2.53
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside-4.62% Downside5,918.89% Upside13.46% Upside
News Sentiment Rating
Positive News

See Recent VEEV News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/2/2025Mizuho
3 of 5 stars
S. Valiquette
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOutperform ➝ Outperform$280.00 ➝ $295.00+5.34%
5/30/2025Citigroup
3 of 5 stars
Tyler Radke
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$265.00 ➝ $329.00+18.28%
5/29/2025Wells Fargo & Company
3 of 5 stars
Stan Berenshteyn
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$285.00 ➝ $300.00+6.69%
5/29/2025Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brian Peterson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOutperform ➝ Outperform$285.00 ➝ $310.00+12.25%
5/29/2025Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Joe Meares
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetHold ➝ Hold$217.00 ➝ $230.00-16.72%
5/29/2025UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Karl Keirstead
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetNeutral ➝ Neutral$250.00 ➝ $285.00+3.20%
5/29/2025Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
David Grossman
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$272.00 ➝ $295.00+6.82%
5/29/2025Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brent Bracelin
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$255.00 ➝ $325.00+17.68%
5/29/2025Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Craig Hettenbach
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetUnderweight ➝ Underweight$201.00 ➝ $210.00-23.88%
5/29/2025Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Saket Kalia
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$285.00 ➝ $300.00+7.46%
5/29/2025Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Ryan MacDonald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$270.00 ➝ $300.00+27.46%
4/16/2025KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Sangita Jain
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOverweight ➝ Overweight$260.00 ➝ $250.00+12.46%
3/20/2025JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Anne Samuel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetNeutral ➝ Neutral$218.00 ➝ $249.00+5.30%
3/6/2025Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Verkhovski
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetSector Perform ➝ Sector Perform$240.00 ➝ $245.00+3.61%
3/6/2025Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Garro
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$280.00 ➝ $280.00+19.63%
3/6/2025Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Joe Vruwink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOutperform ➝ Outperform$283.00 ➝ $285.00+29.36%
1/23/2025The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Gabriela Borges
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Sell$261.00 ➝ $200.00-12.68%
12/6/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetIn-Line ➝ In-Line$220.00 ➝ $245.00-4.09%
12/6/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$280.00 ➝ $290.00+13.44%
12/6/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$275.00 ➝ $285.00+12.20%
12/6/2024Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$210.00 ➝ $270.00+16.55%
10/8/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Degasperi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$286.00+41.70%
10/1/2024Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$233.00 ➝ $249.00+20.00%
8/29/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$180.00 ➝ $192.00-11.20%
7/9/2024BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Larsen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$240.00+31.21%
3/4/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$225.00 ➝ $270.00+21.62%
2/22/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$225.00+2.46%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 03:39 AM ET.


Should I Buy Veeva Systems Stock? VEEV Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, June 9, 2025. Please send any questions or comments about these Veeva Systems pros and cons to contact@marketbeat.com.

Veeva Systems
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Veeva Systems Inc.:

  • The current stock price is around $285, reflecting a strong market position and investor interest in the company.
  • Veeva Systems Inc. reported a quarterly revenue of $759.04 million, exceeding analysts' expectations, indicating robust financial performance.
  • The company has a significant market capitalization of approximately $46.38 billion, showcasing its stability and growth potential in the life sciences software sector.
  • Insider ownership is at 10.30%, which can signal confidence in the company's future prospects and align management's interests with those of shareholders.
  • Recent institutional investments, such as Apella Capital LLC increasing its holdings by 16.3%, suggest growing confidence among large investors in Veeva Systems Inc.'s future growth.

Veeva Systems
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Veeva Systems Inc. for these reasons:

  • The stock has experienced a decline of about 1.7% recently, which may indicate short-term volatility and investor uncertainty.
  • Insider sales, including a senior vice president selling shares, could raise concerns about the company's future performance and insider confidence.
  • The price-to-earnings ratio is relatively high at 70.39, suggesting that the stock may be overvalued compared to its earnings, which could deter value-focused investors.
  • Despite strong revenue, the company has a net margin of 25.07%, which, while healthy, may not be sufficient to sustain high growth expectations in a competitive market.
  • Hedge funds and institutional investors hold a significant 88.20% of the company's stock, which could lead to increased volatility if these investors decide to sell off their positions.

VEEV Forecast - Frequently Asked Questions

According to the research reports of 25 Wall Street equities research analysts, the average twelve-month stock price forecast for Veeva Systems is $269.80, with a high forecast of $329.00 and a low forecast of $192.00.

25 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Veeva Systems in the last year. There are currently 2 sell ratings, 8 hold ratings and 15 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" VEEV shares.

According to analysts, Veeva Systems's stock has a predicted downside of -4.62% based on their 12-month stock forecasts.

Analysts like Veeva Systems less than other "medical" companies. The consensus rating score for Veeva Systems is 2.52 while the average consensus rating score for "medical" companies is 2.81. Learn more on how VEEV compares to other companies.


This page (NYSE:VEEV) was last updated on 6/10/2025 by MarketBeat.com Staff
From Our Partners